- Title
A phase II study of agenT-797 (invariant natural killer T-cells), botensilimab (Fc-enhanced CTLA-4 inhibitor) and balstilimab (anti-PD-1) in patients with advanced, refractory gastroesophageal adenocarcinoma.
- Authors
Cytryn, Samuel Louis; Maron, Steven Brad; Janjigian, Yelena Y.
- Publication
Journal of Clinical Oncology, 2025, Vol 43, pTPS515
- ISSN
0732-183X
- Publication type
Academic Journal
- DOI
10.1200/JCO.2025.43.4_suppl.TPS515